Downbeat retail sales data and Treasury Secretary Scott Bessent's comments are adding to worries about the economy.

U.S. retail sales rebounded marginally in February as consumers pulled back on discretionary spending, reinforcing the ...

The Federal Reserve will keep interest rates steady through the first half of the year, before delivering two reductions ...

A new survey of economists by Bloomberg says they expect two Federal Reserve rate cuts to come in September and December this year, but also weaker growth and higher inflation in 2025.

Independent Advisor Alliance lessened its stake in Kinsale Capital Group, Inc. (NYSE:KNSL – Free Report) by 3.7% during the ...

BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of $12 ...

Stock market corrections of 10% hurt. But research shows that they often don't portend worse things ahead for stocks.

ECN Capital Corp. (TSX: ECN) ("ECN Capital” or the "Company”) today announced that it has entered into an agreement with a syndicate of underwriters (the "Underwriters”) led by CIBC Capital Markets, ...

On Tuesday, BMO Capital Markets began coverage of Avidity Biosciences (NASDAQ:RNA) shares, assigning an Outperform rating and setting a price target of $72.00. Currently trading at $29.58, the stock ...